We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The R&D of new drugs is inextricably linked to substantial financial backing. Within this framework, the role of venture capital firms is immeasurable. Today, we spotlight the renowned venture capital entity, ARCH.